DermatologyInvestigational

Matrixyl Synthe'6 (Palmitoyl Tripeptide-38)

Topical

Overview

Palmitoyl tripeptide-38 is a synthetic lipopeptide designed to stimulate synthesis of six major constituents of the dermal matrix: collagen I, III, and IV, fibronectin, hyaluronic acid, and laminin 5. It is proposed to activate transforming growth factor beta (TGF-beta) signaling in fibroblasts, thereby promoting coordinated extracellular matrix assembly.

Mechanism of Action

The palmitic acid conjugate enhances dermal bioavailability when applied topically..

Research Summary & Key Findings

In vitro studies using cultured human dermal fibroblasts have demonstrated dose-dependent increases in collagen I, III, and IV mRNA expression, along with elevated hyaluronic acid production. A small manufacturer-supported clinical trial reported volumetric improvements in nasolabial fold depth after 60 days of topical use, though peer-reviewed validation is lacking. Histological confirmation of matrix remodeling in human skin has not been extensively published.

Clinical Status

Investigational

Matrixyl Synthe'6 (Palmitoyl Tripeptide-38) is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.

Administration Routes

Topical

Related Peptides in Dermatology

Find a Provider

Find a verified provider who offers Matrixyl Synthe'6 (Palmitoyl Tripeptide-38) therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Matrixyl Synthe'6 (Palmitoyl Tripeptide-38).

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.